FDA approves URL Pharma's Colcrys as gout prophylactic
This article was originally published in Scrip
Executive Summary
The US FDA has approved URL Pharmaceuticals' Colcrys (colchicine) for the prevention of gout flare ups. The drug was approved earlier this year for the treatment of these episodes, for which it is taken at the first sign of a flare.